Company / Cash per Share
Bioventus Inc. Cash per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.82
FY2025
5-year range
$0.66 / $0.97
FY2021-FY2025
Trend
+20.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 5 years, ranging from $0.66 in FY2022 to $0.97 in FY2021.
Based on SEC 10-K filings.
0.82 in FY2025 with a 3-year CAGR of +7.2%.
Remained stable around $0.82 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +7.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share increased 20.7% year-over-year.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.82 | +20.7% |
| FY2024 | $0.68 | -16.7% |
| FY2023 | $0.81 | +22.5% |
| FY2022 | $0.66 | -31.3% |
| FY2021 | $0.97 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026